Stewart CF - Search Results

1

Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report.

Fouladi M, Park JR, Stewart CF, Gilbertson RJ, Schaiquevich P, Sun J, Reid JM, Ames MM, Speights R, Ingle AM, Zwiebel J, Blaney SM, Adamson PC. Fouladi M, et al. Among authors: stewart cf. J Clin Oncol. 2010 Aug 1;28(22):3623-9. doi: 10.1200/JCO.2009.25.9119. Epub 2010 Jul 6. J Clin Oncol. 2010. PMID: 20606092 Free PMC article. Clinical Trial.

2

Changes in the clearance of total and unbound etoposide in patients with liver dysfunction.

Stewart CF, Arbuck SG, Fleming RA, Evans WE. Stewart CF, et al. J Clin Oncol. 1990 Nov;8(11):1874-9. doi: 10.1200/JCO.1990.8.11.1874. J Clin Oncol. 1990. PMID: 2230875

3

Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicity.

Stewart CF, Baker SD, Heideman RL, Jones D, Crom WR, Pratt CB. Stewart CF, et al. J Clin Oncol. 1994 Sep;12(9):1946-54. doi: 10.1200/JCO.1994.12.9.1946. J Clin Oncol. 1994. PMID: 8083716 Clinical Trial.

4

Phase I study of topotecan for pediatric patients with malignant solid tumors.

Pratt CB, Stewart C, Santana VM, Bowman L, Furman W, Ochs J, Marina N, Kuttesch JF, Heideman R, Sandlund JT, et al. Pratt CB, et al. J Clin Oncol. 1994 Mar;12(3):539-43. doi: 10.1200/JCO.1994.12.3.539. J Clin Oncol. 1994. PMID: 8120551 Clinical Trial.

5

Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in children.

Rodman JH, Relling MV, Stewart CF, Synold TW, McLeod H, Kearns C, Stute N, Crom WR, Evans WE. Rodman JH, et al. Among authors: stewart cf. Semin Oncol. 1993 Feb;20(1):18-29. Semin Oncol. 1993. PMID: 8475406 Review.

6

Escalating systemic exposure of continuous infusion topotecan in children with recurrent acute leukemia.

Furman WL, Baker SD, Pratt CB, Rivera GK, Evans WE, Stewart CF. Furman WL, et al. Among authors: stewart cf. J Clin Oncol. 1996 May;14(5):1504-11. doi: 10.1200/JCO.1996.14.5.1504. J Clin Oncol. 1996. PMID: 8622064 Clinical Trial.

7

Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group Study.

Saylors RL 3rd, Stewart CF, Zamboni WC, Wall DA, Bell B, Stine KC, Vietti TJ. Saylors RL 3rd, et al. Among authors: stewart cf. J Clin Oncol. 1998 Mar;16(3):945-52. doi: 10.1200/JCO.1998.16.3.945. J Clin Oncol. 1998. PMID: 9508177 Clinical Trial.

8

Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft models.

Zamboni WC, Stewart CF, Cheshire PJ, Richmond LB, Hanna SK, Luo X, Poquette C, McGovren JP, Houghton JA, Houghton PJ. Zamboni WC, et al. Among authors: stewart cf. Clin Cancer Res. 1998 Mar;4(3):743-53. Clin Cancer Res. 1998. PMID: 9533544

9

Phase I study of DMP 840 in pediatric patients with refractory solid tumors.

Thompson J, Pratt CB, Stewart CF, Avery L, Bowman L, Zamboni WC, Pappo A. Thompson J, et al. Among authors: stewart cf. Invest New Drugs. 1998;16(1):45-9. doi: 10.1023/a:1006014510078. Invest New Drugs. 1998. PMID: 9740543 Clinical Trial.

10

Efficacy of systemic administration of irinotecan against neuroblastoma xenografts.

Thompson J, Zamboni WC, Cheshire PJ, Lutz L, Luo X, Li Y, Houghton JA, Stewart CF, Houghton PJ. Thompson J, et al. Among authors: stewart cf. Clin Cancer Res. 1997 Mar;3(3):423-31. Clin Cancer Res. 1997. PMID: 9815701

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters